Cell therapy startup Immusoft lands deal with Takeda worth potentially more than $900M by Charlotte Schubert on October 14, 2021October 14, 2021 at 10:53 pm Seattle-based cell therapy startup Immusoft will collaborate with pharma giant Takeda to develop treatments targeted to the central nervous system in a deal worth potentially more than $900 million. Immusoft’s… Read More